Infectious Disease Diagnostics Market to 2027 - Global Analysis and Forecasts By Coverage : Product ( Kits and Reagents, Instruments ); Disease Indication ( HIV, Hepatitis, Healthcare Associated Infections (HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other Disease Indications, , ); Technology ( Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Other Technology ); Test Location ( Laboratory Testing, Point of Care Testing, ); End User ( Hospitals, Pathology or Diagnostic Laboratories, Research Institutes, Home-Care Settings, Other End User ) and Geography
Infectious disease are caused by microorganisms such as fungi, virus, bacteria, and other organism species. Infectious disease diagnostics are the procedures utilized by hospitals, clinical laboratories, and others to detect or identify the foreign antigen/organism by using various diagnostic tests. These tests help in the identification of the type of pathogen. Also, the degree of the extent to which the infection is spread in the body. The diagnostic procedure may be carried out with the help of conventional diagnostic tests or point-of-care testing tools.
MARKET DYNAMICS
Global infectious disease diagnostic market is anticipated to be driven by various factors such as the rising prevalence of infectious and vector-borne diseases, and advancement in molecular and immunodiagnostics is projected to propel the growth of the global infectious disease diagnostics market. However, the lack of compiled regulatory guidelines and lack of centralized laboratory facilities in developing and under-developed countries are expected to hinder the market growth of the market. The immunodiagnostic kits and home-based point-of-care diagnostic for the detection of various diseases are expected to be one of the most prevailing trends in the infectious disease diagnostics market.
MARKET SCOPE
The "Global Infectious disease diagnostics market analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of infectious disease diagnostics market with detailed market segmentation by product, application, end user, and geography. Global infectious disease diagnostic market is anticipated to witness high growth during the forecast period. The report provides key statistics on the market status of the leading infectious disease diagnostics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global infectious disease diagnostics market is segmented on the basis of product, disease indication, technology, test location, end user. On the basis of product, the global infectious disease diagnostics market is segmented into reagents & kits and instruments. Based on disease indication, the market is segmented into HIV, hepatitis, healthcare associated infections (HIAs), human papillomavirus (HPV), tuberculosis, influenza, and others. Based on the technology, the market is segmented into immunodiagnostics, polymerase chain reaction (PCR), next generation sequencing (NGS), and others. On the basis of test location, the global infectious disease diagnostics market is segmented in to laboratory testing and point-of-care testing. Similarly, on the basis of end user, the global infectious disease diagnostics market is segmented in to hospitals, pathology/diagnostic, laboratories, research institutes, home-care settings, and others
Get more information on this report :
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infectious disease diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The infectious disease diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting infectious disease diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the infectious disease diagnostics market in these regions.
Get more information on this report :
MARKET PLAYERS
The reports cover key developments in the infectious disease diagnostics market as organic and inorganic growth strategies. The various firm are focusing on organic growth strategies such as product launch, product approvals and others. Inorganic growth strategies activities observed in the market were partnership & collaborations and acquisitions. These activities have acted as a way for the expansion of business and customer base of market players. The market payers from infectious disease diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for infectious disease diagnostics market in the global market. Below is the list of few companies operating in the infectious disease diagnostics market.
The report also includes the profiles of key infectious disease diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
- Danaher
- Abbott
- BD
- F. Hoffmann-La Roche Ltd
- Trinity Biotech
- Cardinal Health
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- AccuBioTech Co., Ltd.
- ACON Laboratories, Inc.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Infectious Disease Diagnostics Market - By Product
1.3.2 Infectious Disease Diagnostics Market - By Disease Indication
1.3.3 Infectious Disease Diagnostics Market - By Technology
1.3.4 Infectious Disease Diagnostics Market - By Test Location
1.3.5 Infectious Disease Diagnostics Market - By End User
1.3.6 Infectious Disease Diagnostics Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFECTIOUS DISEASE DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFECTIOUS DISEASE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFECTIOUS DISEASE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFECTIOUS DISEASE DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. INFECTIOUS DISEASE DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. KITS AND REAGENTS
7.3.1. Overview
7.3.2. Kits and Reagents Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
8. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. HIV
8.3.1. Overview
8.3.2. HIV Market Forecast and Analysis
8.4. HEPATITIS
8.4.1. Overview
8.4.2. Hepatitis Market Forecast and Analysis
8.5. HEALTHCARE ASSOCIATED INFECTIONS (HAIS)
8.5.1. Overview
8.5.2. Healthcare Associated Infections (HAIs) Market Forecast and Analysis
8.6. HUMAN PAPILLOMAVIRUS (HPV)
8.6.1. Overview
8.6.2. Human Papillomavirus (HPV) Market Forecast and Analysis
8.7. TUBERCULOSIS (TB)
8.7.1. Overview
8.7.2. Tuberculosis (TB) Market Forecast and Analysis
8.8. INFLUENZA
8.8.1. Overview
8.8.2. Influenza Market Forecast and Analysis
8.9. OTHER DISEASE INDICATIONS
8.9.1. Overview
8.9.2. Other Disease Indications Market Forecast and Analysis
8.10.
8.10.1. Overview
8.10.2. Market Forecast and Analysis
8.11.
8.11.1. Overview
8.11.2. Market Forecast and Analysis
9. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. IMMUNODIAGNOSTICS
9.3.1. Overview
9.3.2. Immunodiagnostics Market Forecast and Analysis
9.4. POLYMERASE CHAIN REACTION
9.4.1. Overview
9.4.2. Polymerase Chain Reaction Market Forecast and Analysis
9.5. NEXT GENERATION SEQUENCING
9.5.1. Overview
9.5.2. Next Generation Sequencing Market Forecast and Analysis
9.6. OTHER TECHNOLOGY
9.6.1. Overview
9.6.2. Other Technology Market Forecast and Analysis
10. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TEST LOCATION
10.1. OVERVIEW
10.2. TEST LOCATION MARKET FORECASTS AND ANALYSIS
10.3. LABORATORY TESTING
10.3.1. Overview
10.3.2. Laboratory Testing Market Forecast and Analysis
10.4. POINT OF CARE TESTING
10.4.1. Overview
10.4.2. Point of Care Testing Market Forecast and Analysis
10.5.
10.5.1. Overview
10.5.2. Market Forecast and Analysis
11. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS
11.3.1. Overview
11.3.2. Hospitals Market Forecast and Analysis
11.4. PATHOLOGY OR DIAGNOSTIC LABORATORIES
11.4.1. Overview
11.4.2. Pathology or Diagnostic Laboratories Market Forecast and Analysis
11.5. RESEARCH INSTITUTES
11.5.1. Overview
11.5.2. Research Institutes Market Forecast and Analysis
11.6. HOME-CARE SETTINGS
11.6.1. Overview
11.6.2. Home-Care Settings Market Forecast and Analysis
11.7. OTHER END USER
11.7.1. Overview
11.7.2. Other End User Market Forecast and Analysis
12. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Infectious Disease Diagnostics Market Overview
12.1.2 North America Infectious Disease Diagnostics Market Forecasts and Analysis
12.1.3 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
12.1.4 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
12.1.5 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
12.1.6 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
12.1.7 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
12.1.8 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
12.1.8.1 United States Infectious Disease Diagnostics Market
12.1.8.1.1 United States Infectious Disease Diagnostics Market by Product
12.1.8.1.2 United States Infectious Disease Diagnostics Market by Disease Indication
12.1.8.1.3 United States Infectious Disease Diagnostics Market by Technology
12.1.8.1.4 United States Infectious Disease Diagnostics Market by Test Location
12.1.8.1.5 United States Infectious Disease Diagnostics Market by End User
12.1.8.2 Canada Infectious Disease Diagnostics Market
12.1.8.2.1 Canada Infectious Disease Diagnostics Market by Product
12.1.8.2.2 Canada Infectious Disease Diagnostics Market by Disease Indication
12.1.8.2.3 Canada Infectious Disease Diagnostics Market by Technology
12.1.8.2.4 Canada Infectious Disease Diagnostics Market by Test Location
12.1.8.2.5 Canada Infectious Disease Diagnostics Market by End User
12.1.8.3 Mexico Infectious Disease Diagnostics Market
12.1.8.3.1 Mexico Infectious Disease Diagnostics Market by Product
12.1.8.3.2 Mexico Infectious Disease Diagnostics Market by Disease Indication
12.1.8.3.3 Mexico Infectious Disease Diagnostics Market by Technology
12.1.8.3.4 Mexico Infectious Disease Diagnostics Market by Test Location
12.1.8.3.5 Mexico Infectious Disease Diagnostics Market by End User
12.2. EUROPE
12.2.1 Europe Infectious Disease Diagnostics Market Overview
12.2.2 Europe Infectious Disease Diagnostics Market Forecasts and Analysis
12.2.3 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
12.2.4 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
12.2.5 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
12.2.6 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
12.2.7 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
12.2.8 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Infectious Disease Diagnostics Market
12.2.8.1.1 Germany Infectious Disease Diagnostics Market by Product
12.2.8.1.2 Germany Infectious Disease Diagnostics Market by Disease Indication
12.2.8.1.3 Germany Infectious Disease Diagnostics Market by Technology
12.2.8.1.4 Germany Infectious Disease Diagnostics Market by Test Location
12.2.8.1.5 Germany Infectious Disease Diagnostics Market by End User
12.2.8.2 France Infectious Disease Diagnostics Market
12.2.8.2.1 France Infectious Disease Diagnostics Market by Product
12.2.8.2.2 France Infectious Disease Diagnostics Market by Disease Indication
12.2.8.2.3 France Infectious Disease Diagnostics Market by Technology
12.2.8.2.4 France Infectious Disease Diagnostics Market by Test Location
12.2.8.2.5 France Infectious Disease Diagnostics Market by End User
12.2.8.3 Italy Infectious Disease Diagnostics Market
12.2.8.3.1 Italy Infectious Disease Diagnostics Market by Product
12.2.8.3.2 Italy Infectious Disease Diagnostics Market by Disease Indication
12.2.8.3.3 Italy Infectious Disease Diagnostics Market by Technology
12.2.8.3.4 Italy Infectious Disease Diagnostics Market by Test Location
12.2.8.3.5 Italy Infectious Disease Diagnostics Market by End User
12.2.8.4 Spain Infectious Disease Diagnostics Market
12.2.8.4.1 Spain Infectious Disease Diagnostics Market by Product
12.2.8.4.2 Spain Infectious Disease Diagnostics Market by Disease Indication
12.2.8.4.3 Spain Infectious Disease Diagnostics Market by Technology
12.2.8.4.4 Spain Infectious Disease Diagnostics Market by Test Location
12.2.8.4.5 Spain Infectious Disease Diagnostics Market by End User
12.2.8.5 United Kingdom Infectious Disease Diagnostics Market
12.2.8.5.1 United Kingdom Infectious Disease Diagnostics Market by Product
12.2.8.5.2 United Kingdom Infectious Disease Diagnostics Market by Disease Indication
12.2.8.5.3 United Kingdom Infectious Disease Diagnostics Market by Technology
12.2.8.5.4 United Kingdom Infectious Disease Diagnostics Market by Test Location
12.2.8.5.5 United Kingdom Infectious Disease Diagnostics Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Infectious Disease Diagnostics Market Overview
12.3.2 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis
12.3.3 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
12.3.4 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
12.3.5 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
12.3.6 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
12.3.7 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Infectious Disease Diagnostics Market
12.3.8.1.1 Australia Infectious Disease Diagnostics Market by Product
12.3.8.1.2 Australia Infectious Disease Diagnostics Market by Disease Indication
12.3.8.1.3 Australia Infectious Disease Diagnostics Market by Technology
12.3.8.1.4 Australia Infectious Disease Diagnostics Market by Test Location
12.3.8.1.5 Australia Infectious Disease Diagnostics Market by End User
12.3.8.2 China Infectious Disease Diagnostics Market
12.3.8.2.1 China Infectious Disease Diagnostics Market by Product
12.3.8.2.2 China Infectious Disease Diagnostics Market by Disease Indication
12.3.8.2.3 China Infectious Disease Diagnostics Market by Technology
12.3.8.2.4 China Infectious Disease Diagnostics Market by Test Location
12.3.8.2.5 China Infectious Disease Diagnostics Market by End User
12.3.8.3 India Infectious Disease Diagnostics Market
12.3.8.3.1 India Infectious Disease Diagnostics Market by Product
12.3.8.3.2 India Infectious Disease Diagnostics Market by Disease Indication
12.3.8.3.3 India Infectious Disease Diagnostics Market by Technology
12.3.8.3.4 India Infectious Disease Diagnostics Market by Test Location
12.3.8.3.5 India Infectious Disease Diagnostics Market by End User
12.3.8.4 Japan Infectious Disease Diagnostics Market
12.3.8.4.1 Japan Infectious Disease Diagnostics Market by Product
12.3.8.4.2 Japan Infectious Disease Diagnostics Market by Disease Indication
12.3.8.4.3 Japan Infectious Disease Diagnostics Market by Technology
12.3.8.4.4 Japan Infectious Disease Diagnostics Market by Test Location
12.3.8.4.5 Japan Infectious Disease Diagnostics Market by End User
12.3.8.5 South Korea Infectious Disease Diagnostics Market
12.3.8.5.1 South Korea Infectious Disease Diagnostics Market by Product
12.3.8.5.2 South Korea Infectious Disease Diagnostics Market by Disease Indication
12.3.8.5.3 South Korea Infectious Disease Diagnostics Market by Technology
12.3.8.5.4 South Korea Infectious Disease Diagnostics Market by Test Location
12.3.8.5.5 South Korea Infectious Disease Diagnostics Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Infectious Disease Diagnostics Market Overview
12.4.2 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis
12.4.3 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
12.4.4 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
12.4.5 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
12.4.6 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
12.4.7 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Infectious Disease Diagnostics Market
12.4.8.1.1 South Africa Infectious Disease Diagnostics Market by Product
12.4.8.1.2 South Africa Infectious Disease Diagnostics Market by Disease Indication
12.4.8.1.3 South Africa Infectious Disease Diagnostics Market by Technology
12.4.8.1.4 South Africa Infectious Disease Diagnostics Market by Test Location
12.4.8.1.5 South Africa Infectious Disease Diagnostics Market by End User
12.4.8.2 Saudi Arabia Infectious Disease Diagnostics Market
12.4.8.2.1 Saudi Arabia Infectious Disease Diagnostics Market by Product
12.4.8.2.2 Saudi Arabia Infectious Disease Diagnostics Market by Disease Indication
12.4.8.2.3 Saudi Arabia Infectious Disease Diagnostics Market by Technology
12.4.8.2.4 Saudi Arabia Infectious Disease Diagnostics Market by Test Location
12.4.8.2.5 Saudi Arabia Infectious Disease Diagnostics Market by End User
12.4.8.3 U.A.E Infectious Disease Diagnostics Market
12.4.8.3.1 U.A.E Infectious Disease Diagnostics Market by Product
12.4.8.3.2 U.A.E Infectious Disease Diagnostics Market by Disease Indication
12.4.8.3.3 U.A.E Infectious Disease Diagnostics Market by Technology
12.4.8.3.4 U.A.E Infectious Disease Diagnostics Market by Test Location
12.4.8.3.5 U.A.E Infectious Disease Diagnostics Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Infectious Disease Diagnostics Market Overview
12.5.2 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis
12.5.3 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
12.5.4 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
12.5.5 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
12.5.6 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
12.5.7 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
12.5.8 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Infectious Disease Diagnostics Market
12.5.8.1.1 Brazil Infectious Disease Diagnostics Market by Product
12.5.8.1.2 Brazil Infectious Disease Diagnostics Market by Disease Indication
12.5.8.1.3 Brazil Infectious Disease Diagnostics Market by Technology
12.5.8.1.4 Brazil Infectious Disease Diagnostics Market by Test Location
12.5.8.1.5 Brazil Infectious Disease Diagnostics Market by End User
12.5.8.2 Argentina Infectious Disease Diagnostics Market
12.5.8.2.1 Argentina Infectious Disease Diagnostics Market by Product
12.5.8.2.2 Argentina Infectious Disease Diagnostics Market by Disease Indication
12.5.8.2.3 Argentina Infectious Disease Diagnostics Market by Technology
12.5.8.2.4 Argentina Infectious Disease Diagnostics Market by Test Location
12.5.8.2.5 Argentina Infectious Disease Diagnostics Market by End User
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. INFECTIOUS DISEASE DIAGNOSTICS MARKET, KEY COMPANY PROFILES
14.1. DANAHER
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ABBOTT
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BD
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. F. HOFFMANN-LA ROCHE LTD
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. TRINITY BIOTECH
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. CARDINAL HEALTH
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BIOMéRIEUX SA
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. BIO-RAD LABORATORIES, INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ACCUBIOTECH CO., LTD.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. ACON LABORATORIES, INC.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. Danaher
2. Abbott
3. BD
4. F. Hoffmann-La Roche Ltd
5. Trinity Biotech
6. Cardinal Health
7. bioMérieux SA
8. Bio-Rad Laboratories, Inc.
9. AccuBioTech Co., Ltd.
10. ACON Laboratories, Inc.